Table 1. Presenting Features of Patients... | American Society of Hematology

Table 1.

Presenting Features of Patients Whose Cells Were Cryopreserved at Diagnosis

Patient	WCC* (×10⁹/L)	Ph⁺ Metaphases*	FISH† BCR-ABL⁺ (%)	Immunophenotype†
Patient	WCC* (×10⁹/L)	Ph⁺ Metaphases*	FISH† BCR-ABL⁺ (%)	CD34	CD33	CD3	CD19
01	222	100%	ND	24	60	17	3
02	142	100%	48	22	28	12	3
03	112	100%	50	7	30	49	2
04	133	100%	ND	18	27	48	4
05	71	100%	ND	9	ND	ND	ND
06	370	100%‡	37	5	54	26	9
07	192	100%	ND	ND	ND	ND	ND
08	284	100%	51	21	37	27	4
09	214	100%	ND	3	26	49	3
10	98	100%	ND	3	ND	ND	ND
11	70	82%	ND	20	ND	ND	ND
12	109	100%§	ND	25	50	15	1
13	35	100%	43	31	52	18	2
14	376	100%	ND	20	ND	ND	ND
15	39	100%	ND	3	7	49	1

Patient	WCC* (×10⁹/L)	Ph⁺ Metaphases*	FISH† BCR-ABL⁺ (%)	Immunophenotype†
Patient	WCC* (×10⁹/L)	Ph⁺ Metaphases*	FISH† BCR-ABL⁺ (%)	CD34	CD33	CD3	CD19
01	222	100%	ND	24	60	17	3
02	142	100%	48	22	28	12	3
03	112	100%	50	7	30	49	2
04	133	100%	ND	18	27	48	4
05	71	100%	ND	9	ND	ND	ND
06	370	100%‡	37	5	54	26	9
07	192	100%	ND	ND	ND	ND	ND
08	284	100%	51	21	37	27	4
09	214	100%	ND	3	26	49	3
10	98	100%	ND	3	ND	ND	ND
11	70	82%	ND	20	ND	ND	ND
12	109	100%§	ND	25	50	15	1
13	35	100%	43	31	52	18	2
14	376	100%	ND	20	ND	ND	ND
15	39	100%	ND	3	7	49	1

After thawing, FISH and immunophenotype were performed before infusion into mice.

Abbreviation: ND, not determined.

At diagnosis.

Before infusion into mice on thawed PB monuclear cells.

t(9;22)[73%]t(9;22), del(20p)[27%].

t(3;9;22)[100%].